Answers are grounded in this paper and cite their sources.
Background Early prediction of adverse neonatal outcomes remains challenging. This study evaluated the associations and predictive performance of first-trimester pregnancy-associated plasma protein-A (PAPP-A), free β-human chorionic gonadotropin (β-hCG), nuchal translucency (NT), and maternal age. Methods This prospective cohort enrolled 1244 singleton pregnancies at 11–13 + 6 weeks, with 1229 analyzed after 15 were lost to follow-up. Primary outcome comprised preterm birth, low birth weight, or neonatal intensive care unit (NICU) admission. Associations were assessed using multivariable logistic regression. Predictive performance was evaluated using receiver operating characteristic analysis, calibration, decision-curve analysis, and clinical impact curves. Models underwent held-out validation (30%), with additional bootstrap internal validation (1000 resamples) of the combined model. Results Composite adverse neonatal outcomes occurred in 469 pregnancies (38.2%). Lower PAPP-A MoM was independently associated with composite outcome (adjusted OR 0.274, 95% CI 0.188–0.399; p < 0.001), particularly low birth weight and NICU admission. In an exploratory model incorporating HDP and SGA, the PAPP-A point estimate reversed direction and became statistically nonsignificant (adjusted OR 1.510, 95% CI 0.942–2.420; p = 0.087), warranting cautious interpretation because of potential downstream adjustment bias. Discrimination for the composite adverse neonatal outcome was limited for PAPP-A alone (AUC 0.620, 95% CI 0.563–0.673) and the combined model (AUC 0.610, 95% CI 0.553–0.665), with no significant improvement following combination (paired DeLong p = 0.315). Bootstrap internal validation yielded an optimism-corrected development-sample AUC of 0.642, whereas the held-out validation AUC was 0.610. Decision-curve findings were exploratory and did not establish clinical benefit. Neither model demonstrated sufficient discrimination for individual-level risk stratification. Conclusion Although lower PAPP-A was independently associated with adverse neonatal outcomes, neither PAPP-A alone nor the combined model provided reliable individual-level prediction. Further development and external validation of integrated models are warranted.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: